Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Video

Updated: Jun 21, 2026

Multidimensional Coculture System to Model Lung Squamous Carcinoma Progression
07:53

Multidimensional Coculture System to Model Lung Squamous Carcinoma Progression

Published on: March 17, 2020

Dithiolethione modified valproate and diclofenac increase E-cadherin expression and decrease proliferation of

Terry W Moody1, Christopher Switzer, Wilmarie Santana-Flores

  • 1National Cancer Institute, Office of the Director, Center for Cancer Research, Bethesda, MD 20892-1500, USA. moodyt@mail.nih.gov

Lung Cancer (Amsterdam, Netherlands)
|July 25, 2009
PubMed
Summary

Related Concept Videos

Cadherins in Tissue Organization01:19

Cadherins in Tissue Organization

The cadherins are a superfamily of cell adhesion molecules comprising over 180 variants, with specific tissues expressing a particular combination of cadherin types. Cadherins generally exhibit homophilic binding; i.e., cadherins on one cell bind to cadherins of the same or closely related type on another cell. Thus, cells of the same type have a specific affinity to bind to each other and sort themselves into clusters to form tissues.
Cell Sorting During Development
Cell sorting plays an...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Selective allosteric regulation of Leishmania braziliensis Hsp90 through a parasite-specific regulatory hub.

International journal of biological macromolecules·2026
Same author

Nitric oxide-driven Warburg reprogramming at the NOS2-COX2 axis: An integrative engine of cancer hallmarks.

Redox biology·2026
Same author

NOS2 and COX2 impact the spatial landscape of CD8<sup>+</sup> T cells in ER-breast cancer, providing novel mechanistic insight that drives tumor progression and poor survival.

Redox biology·2026
Same author

SPAC: a scalable and integrated enterprise platform for single-cell spatial analysis.

BMC bioinformatics·2026
Same author

RETRACTED: Waheed et al. Nitric Oxide Donor DETA/NO Inhibits the Growth of Endometrial Cancer Cells by Upregulating the Expression of RASSF1 and CDKN1A. <i>Molecules</i> 2019, <i>24</i>, 3722.

Molecules (Basel, Switzerland)·2025
Same author

Nitrate metabolism and periodontal health: The roles of nitric oxide in microbial killing and immunoregulation.

Periodontology 2000·2025
This summary is machine-generated.

Modified valproate and diclofenac, known as S-valproate and S-diclofenac, show promise in inhibiting non-small cell lung cancer (NSCLC) growth and reducing prostaglandin E2 levels. These compounds may be beneficial for NSCLC chemoprevention and therapy.

Area of Science:

  • Oncology
  • Pharmacology
  • Cancer Research

Background:

  • Non-small cell lung cancer (NSCLC) remains a leading cause of cancer mortality worldwide.
  • Prostaglandin E2 (PGE2) and cyclooxygenase-2 (COX-2) are implicated in NSCLC development and progression.
  • Novel therapeutic strategies targeting these pathways are needed for effective NSCLC treatment.

Purpose of the Study:

  • To investigate the effects of dithiolethione-modified valproate, diclofenac, and sulindac on NSCLC cells.
  • To evaluate the potential of these modified drugs in NSCLC chemoprevention and therapy.
  • To elucidate the mechanisms underlying their anti-cancer effects in NSCLC.

Main Methods:

  • In vitro studies using NSCLC cell lines (A549, NCI-H1299) to assess cell growth inhibition and PGE2 levels.

Related Experiment Videos

Last Updated: Jun 21, 2026

Multidimensional Coculture System to Model Lung Squamous Carcinoma Progression
07:53

Multidimensional Coculture System to Model Lung Squamous Carcinoma Progression

Published on: March 17, 2020

  • In vivo xenograft models in nude mice to evaluate tumor proliferation.
  • MTT assays and Western blot analysis to determine mechanisms of action, including apoptosis, E-cadherin, vimentin, and ZEB1 expression.
  • Main Results:

    • S-valproate and S-diclofenac significantly reduced PGE2 levels in NSCLC cells.
    • In vitro, S-valproate and S-diclofenac inhibited clonal growth of NSCLC cells.
    • In vivo, S-valproate and S-diclofenac suppressed xenograft tumor proliferation without affecting body weight.
    • These agents modulated E-cadherin, vimentin, and ZEB1 protein expression.

    Conclusions:

    • S-valproate and S-diclofenac demonstrate significant anti-proliferative effects on NSCLC cells in vitro and in vivo.
    • The reduction in PGE2 levels and modulation of key proteins suggest a potential therapeutic role.
    • These modified drugs may be valuable agents for the chemoprevention and/or therapy of NSCLC.